Regis A. Vilchez,Lino X. Rodrigues, JR.,Barry M. Bernstein,Thomas J. Podsadecki,Scott C. Brun,Daniel E. Cohen,Rajeev M. Menon,Amit Khatri,Sven Mensing,Sandeep Dutta,Walid M. Awni,Emily O. Dumas,Cheri
申请号：
US14320843
公开号：
US20150011481A1
申请日:
2014.07.01
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention features interferon-free therapies for treating HCV genotype 1b, 2, 3 or 4. In one aspect, the therapies comprise administering Compound 1, ritonavir, and Compound 2 to a subject infected with HCV genotype 1b or 4, wherein the therapies do not include administration of any interferon, and the therapies last for 12 weeks. Preferably, the therapies do not include administration of any ribavirin.
